IBM spent several billion dollars on acquisitions to build up Watson. Former senior IBM executive John Kelly once touted the initiative as a “bet the ranch” move. It didn’t live up to the hype. Watson Health has struggled for market share in the U.S. and abroad and currently isn’t profitable.
The decision to put its flagship Watson Health business up for sale underscores the wider challenge tech companies face in healthcare.
Comments are closed.